
RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death
Keywords: 5-ALA; 5-aminolevulinic acid; MK2; MAP Kinase-Activated Protein kinase 2; p38; Mitogen-Activated Protein kinase p38; PDT; Photodynamic Therapy; RIP; Receptor Interacting Protein; TSC; Tuberous Sclerosis; YWHA; Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxy